Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander I Klimov

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Protocols in Microbiology|May 21, 2013
Influenza: propagation, quantification, and storageAmanda L Balish, Jacqueline M Katz, Alexander I Klimov
JAMA|February 4, 2006
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United StatesRick A Bright, David K Shay, Bo Shu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2010
Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivirHa T Nguyen, Alicia M Fry, P Ann Loveless, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assaysHa T Nguyen, Tiffany G Sheu, Vasiliy P Mishin, et al.
Antiviral Research|November 6, 2009
Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencingTiffany G Sheu, Varough M Deyde, Rebecca J Garten, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) virusesKatrina Sleeman, Vasiliy P Mishin, Varough M Deyde, et al.
Plos One|March 21, 2014
Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccinesSvetlana V Shcherbik, Nicholas C Pearce, Marnie L Levine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2010
Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United StatesNila J Dharan, Larisa V Gubareva, Alexander I Klimov, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2009
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing methodVarough M Deyde, Tung Nguyen, Rick A Bright, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencingVarough M Deyde, Tiffany G Sheu, A Angelica Trujillo, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Protocols in Microbiology|May 21, 2013
Influenza: propagation, quantification, and storageAmanda L Balish, Jacqueline M Katz, Alexander I Klimov
JAMA|February 4, 2006
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United StatesRick A Bright, David K Shay, Bo Shu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2010
Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivirHa T Nguyen, Alicia M Fry, P Ann Loveless, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assaysHa T Nguyen, Tiffany G Sheu, Vasiliy P Mishin, et al.
Antiviral Research|November 6, 2009
Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencingTiffany G Sheu, Varough M Deyde, Rebecca J Garten, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) virusesKatrina Sleeman, Vasiliy P Mishin, Varough M Deyde, et al.
Plos One|March 21, 2014
Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccinesSvetlana V Shcherbik, Nicholas C Pearce, Marnie L Levine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2010
Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United StatesNila J Dharan, Larisa V Gubareva, Alexander I Klimov, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2009
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing methodVarough M Deyde, Tung Nguyen, Rick A Bright, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencingVarough M Deyde, Tiffany G Sheu, A Angelica Trujillo, et al.
Pageof 6